Vericel VCEL Stock
Vericel Price Chart
Vericel VCEL Financial and Trading Overview
| Vericel stock price | 39.77 USD |
| Previous Close | 33.66 USD |
| Open | 33.57 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 800 |
| Day's Range | 33.23 - 34.4 USD |
| 52 Week Range | 17.3 - 35.78 USD |
| Volume | 315.87K USD |
| Avg. Volume | 283.46K USD |
| Market Cap | 1.63B USD |
| Beta (5Y Monthly) | 1.772887 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.2 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 39.25 USD |
VCEL Valuation Measures
| Enterprise Value | 1.56B USD |
| Trailing P/E | N/A |
| Forward P/E | 490.4286 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.644572 |
| Price/Book (mrq) | 8.408033 |
| Enterprise Value/Revenue | 9.217 |
| Enterprise Value/EBITDA | -113.939 |
Trading Information
Vericel Stock Price History
| Beta (5Y Monthly) | 1.772887 |
| 52-Week Change | 47.65% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 35.78 USD |
| 52 Week Low | 17.3 USD |
| 50-Day Moving Average | 32.37 USD |
| 200-Day Moving Average | 27.7 USD |
VCEL Share Statistics
| Avg. Volume (3 month) | 283.46K USD |
| Avg. Daily Volume (10-Days) | 312.19K USD |
| Shares Outstanding | 47.56M |
| Float | 43.88M |
| Short Ratio | 19.47 |
| % Held by Insiders | 0.77% |
| % Held by Institutions | 108.62% |
| Shares Short | 5.6M |
| Short % of Float | 17.05% |
| Short % of Shares Outstanding | 11.76% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -10.10% |
| Operating Margin (ttm) | -10.60% |
| Gross Margin | 66.65% |
| EBITDA Margin | -8.089% |
Management Effectiveness
| Return on Assets (ttm) | -4.44% |
| Return on Equity (ttm) | -9.33% |
Income Statement
| Revenue (ttm) | 169.31M USD |
| Revenue Per Share (ttm) | 3.59 USD |
| Quarterly Revenue Growth (yoy) | 13.70% |
| Gross Profit (ttm) | 109.79M USD |
| EBITDA | -13696000 USD |
| Net Income Avi to Common (ttm) | -17113000 USD |
| Diluted EPS (ttm) | -0.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 119.28M USD |
| Total Cash Per Share (mrq) | 2.51 USD |
| Total Debt (mrq) | 46.88M USD |
| Total Debt/Equity (mrq) | 24.17 USD |
| Current Ratio (mrq) | 6.175 |
| Book Value Per Share (mrq) | 4.083 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 22.08M USD |
| Levered Free Cash Flow (ttm) | 14.59M USD |
Profile of Vericel
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 64 Sidney Street |
| ZIP | 02139 |
| Phone | 617 588 5555 |
| Website | https://vcel.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 305 |
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Q&A For Vericel Stock
What is a current VCEL stock price?
Vericel VCEL stock price today per share is 39.77 USD.
How to purchase Vericel stock?
You can buy VCEL shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vericel?
The stock symbol or ticker of Vericel is VCEL.
Which industry does the Vericel company belong to?
The Vericel industry is Biotechnology.
How many shares does Vericel have in circulation?
The max supply of Vericel shares is 50.14M.
What is Vericel Price to Earnings Ratio (PE Ratio)?
Vericel PE Ratio is 198.85000000 now.
What was Vericel earnings per share over the trailing 12 months (TTM)?
Vericel EPS is 0.2 USD over the trailing 12 months.
Which sector does the Vericel company belong to?
The Vericel sector is Healthcare.
Vericel VCEL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17022.9 USD — |
+1.88
|
2.91B USD — | 16744.97 USD — | 17046.24 USD — | — - | 2.91B USD — |
| NASDAQ Composite Total Return I XCMP | 20789.58 USD — |
+1.65
|
— — | 20497.47 USD — | 20866.26 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2043.81 USD — |
+0.96
|
— — | 2024.76 USD — | 2046.33 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2724.54 USD — |
+1.19
|
— — | 2691.56 USD — | 2727.1 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 922.67 USD — |
+1.21
|
— — | 911.02 USD — | 925.22 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 101.72 USD — |
+1.02
|
— — | 100.62 USD — | 102.01 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1869.16 USD — |
+1.59
|
— — | 1840.92 USD — | 1873.1 USD — | — - | — — |
- {{ link.label }} {{link}}